Global Levofloxacin Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Levofloxacin market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Levofloxacin market."
Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic. It is used to treat a number of bacterial infections including acute bacterial sinusitis, pneumonia, urinary tract infections, chronic prostatitis, and some types of gastroenteritis. Along with other antibiotics it may be used to treat tuberculosis, meningitis, or pelvic inflammatory disease. It is available by mouth, intravenously, and in eye drop form.
Factors such as increasing incidences of bacterial infections such as pneumonia & urinary tract infections (UTI) and broad spectrum efficacy drive the market growth. 
However, side effects associated with levofloxacin such as tendon inflammation, psychosis, and seizures restrain the market growth. 
Furthermore, rising geriatric population and growing initiatives by the government to spread awareness about severe infections are expected to further drive the market growth.

The global Levofloxacin market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Levofloxacin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Levofloxacin market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Alna Biotech Private
    Allenge India Pharma
    Bestochem
    Divine Savior Healthcare
    Glenmark Pharmaceuticals
    Pax Healthcare
    Aden Healthcare
    Lupin Pharmaceuticals
    Dr. Reddys Laboratories
    Zydus Cadila

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    250 mg
    500 mg
    750 mg

Segment by Application
    Pneumonia
    Skin Infection
    Kidney Infection
    Bladder Infection
    Others